These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12768929)
1. AP-1 is present in nuclear extracts of lymphocytes from lepromatous leprosy patients. Huizar-López R; Santerre A; Madrid-Marina V; Peralta-Zaragoza O; Villalobos-Arámbula A; Islas-Rodríguez A Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):274-7. PubMed ID: 12768929 [No Abstract] [Full Text] [Related]
2. Studies on lymphokine production in lepromatous leprosy patients. Munno I; Pellegrino NM; Fumo G; Barbieri G; Jirillo E Cytobios; 1990; 62(250-251):141-7. PubMed ID: 1977562 [TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination. Gangal SG; Chiplunkar SV; Shinde SR; Samson PD; Deo MG Trop Med Parasitol; 1990 Sep; 41(3):314-6. PubMed ID: 1701562 [No Abstract] [Full Text] [Related]
4. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses. Hasan Z; Mahmood A; Zafar S; Khan AA; Hussain R Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):35-44. PubMed ID: 15217317 [TBL] [Abstract][Full Text] [Related]
5. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Chattree V; Khanna N; Rao DN Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060 [TBL] [Abstract][Full Text] [Related]
6. Immunological profile of treated lepromatous leprosy patients. Joshi B; Girdhar BK; Mohanty KK; Beuria MK; Girdhar A; Sengupta U Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):195-203. PubMed ID: 11875763 [TBL] [Abstract][Full Text] [Related]
7. The role of rIL-2 in the modulation of cellular immunity in resistance to infection. Kaplan G Behring Inst Mitt; 1991 Feb; (88):228-9. PubMed ID: 2049043 [No Abstract] [Full Text] [Related]
8. T cell unresponsiveness in lepromatous leprosy. Kamradt T J Rheumatol; 1993 May; 20(5):904-6. PubMed ID: 8336323 [TBL] [Abstract][Full Text] [Related]
9. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction. Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031 [TBL] [Abstract][Full Text] [Related]
10. Immunology of a burnt-out lepromatous leprosy patient. Baliña LN; Jotimliansky L; Sasiain MC; Minnucci F; Kien MC; Chouela E Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):102-4. PubMed ID: 1602187 [No Abstract] [Full Text] [Related]
11. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284 [TBL] [Abstract][Full Text] [Related]
12. Clinical, immunological and histological aspects of an uncommon type II reaction in patients with lepromatous leprosy. Esquenazi D; Moreira AL; Miranda A; Nery JA; Alvarenga FF; Sarno EN; Pereira GM Clin Exp Dermatol; 2008 May; 33(3):294-7. PubMed ID: 18261142 [TBL] [Abstract][Full Text] [Related]
13. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy. Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578 [TBL] [Abstract][Full Text] [Related]
14. Detection of interleukin-2 receptor (IL-2r) by indirect immunofluorescence with anti-Tac monoclonal antibody on the surface of T lymphocytes from patients with lepromatous leprosy. Fafutis-Morris M; Mejia-Arreguin S; Gonzalez-Mendoza A Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):126-8. PubMed ID: 2181043 [No Abstract] [Full Text] [Related]
15. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736 [TBL] [Abstract][Full Text] [Related]
16. Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18. Lopez Roa RI; Guerrero Velásquez C; Alvarado Navarro A; Montoya Buelna M; Garcia Niebla C; Fafutis Morris M Int Immunopharmacol; 2008 Dec; 8(13-14):1715-20. PubMed ID: 18708162 [TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses of healthy and Mycobacterium leprae-inoculated armadillos (Dasypus novemcinctus). Rivero-Nava L; Quesada-Pascual F; Estrada-Garcia I; Estrada-Parra S; Santos-Argumedo L Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):485-7. PubMed ID: 10347570 [No Abstract] [Full Text] [Related]
18. HLA and leprosy in the pre and postgenomic eras. Geluk A; Ottenhoff TH Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267 [TBL] [Abstract][Full Text] [Related]
19. Editorial: Lepromatous leprosy, lipids, and lessons in immunology: what we can learn by using modern methods to study an ancient disease. Fink MP J Leukoc Biol; 2010 Mar; 87(3):361-3. PubMed ID: 20194162 [No Abstract] [Full Text] [Related]
20. Tumor necrosis factor (TNF) production in leprosy patients. Kaur I; Agnihotri N; Mehta M; Dogra S; Ganguly NK Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):249-50. PubMed ID: 11875771 [No Abstract] [Full Text] [Related] [Next] [New Search]